Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Planned sale Chief Legal Officer sold 2,799 shares at $33.54 ($93,878)
  2. 4 Planned sale Chief Medical Officer sold 2,909 shares at $33.54 ($97,568)
  3. 4 Planned sale Chief Financial Officer sold 1,780 shares at $33.54 ($59,701)
  4. 4 Planned sale Chief Commercial Officer sold 2,770 shares at $33.54 ($92,906)
  5. 4 Planned sale Chief Executive Officer sold 18,700 shares at $33.54 ($627,198)
  6. 4 Option exercise Director acquired 2,120 shares (option exercise)
  7. 4 Option exercise Director acquired 2,120 shares (option exercise)
  8. 4 Option exercise Director acquired 2,120 shares (option exercise)
  9. 4 Option exercise Director acquired 2,120 shares (option exercise)
  10. 4 Option exercise Director acquired 2,120 shares (option exercise)
  11. 4 Option exercise Director acquired 2,120 shares (option exercise)
  12. 4 Option exercise Director acquired 2,120 shares (option exercise)
  13. 4 Option exercise Director acquired 2,120 shares (option exercise)
  14. 4 Option exercise Director acquired 1,977 shares (option exercise)
  15. 4 Option exercise Director acquired 1,977 shares (option exercise)
  16. 4 Planned sale Director sold 7,497 shares at $25.90 ($194,172)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale Chief Legal Officer sold 4,005 shares at $35.54 ($142,338)
  20. 4 Planned sale Chief Financial Officer sold 2,275 shares at $35.54 ($80,854)

Page 4 of 38 · 758 filings